BMJ  2005;331:1359 (10 December), doi:10.1136/bmj.331.7529.1359-b

News roundup

Drug companies told that sponsoring patients' groups might help win approval for their products

Canberra Bob Burton

The Australian pharmaceutical industry is giving its members new advice on how to work more closely with the health charity sector and benefit from increased sponsorship of patients’ groups.

The new guide says that companies that sponsor non-profit groups might find that it increases their chances of getting approval for their drugs in the government’s pharmaceutical benefits scheme. Under the scheme, the government substantially subsidises the prices to consumers.

The Australian Consumers Association has expressed alarm at the development. The association’s health spokeswoman, Lisa Tait, said that the association was worried that drug companies would use patients’ groups to lobby for their products. "It is really inappropriate for drug companies to try and use patient groups as a front to lobby government. That is clearly inappropriate, especially at a time when there is such financial stress on the scheme," Ms Tait said.

Ms Tait said that the . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Access jobs at BMJ Careers
Whats new online at Student BMJ